We are live on ! Find out more
ELOX

Eloxx Pharmaceuticals, Inc. Common Stock
ELOX

Delisted

ELOX was delisted on the 13th of October, 2023.

Back to rankings

4 hedge funds and large institutions have $109K invested in Eloxx Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% less ownership

Funds ownership: 24% → 0% (-24%)

78% less funds holding

Funds holding: 18 → 4 (-14)

96% less capital invested

Capital invested by funds: $2.5M → $109K (-$2.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 14

Holders
4
Holders Change
-14
Holders Change %
-77.78%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.32M
2
SCM
Silverarc Capital Management
Massachusetts
-$260K
3
AFG
American Financial Group
Ohio
-$178K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$100K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$93.3K

ELOX Hedge Fund Activity: Q4 2023 in Review

4 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) for Q4 2023, worth a combined $109K — down 96% from $2.5M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ELOX and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Armistice Capital, exiting entirely with an estimated $1.32M sold.

  • 4 institutional investors held Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) as of Q4 2023, down from 18 in Q3 2023.
  • Funds reported $109K of Eloxx Pharmaceuticals, Inc. Common Stock stock for Q4 2023, down 96% quarter-over-quarter.
  • 0 funds opened new Eloxx Pharmaceuticals, Inc. Common Stock positions in Q4 2023 and 14 closed out, a net change of -14 holders.
  • The largest Eloxx Pharmaceuticals, Inc. Common Stock seller in Q4 2023 was Armistice Capital, an estimated $1.32M sold.

Based on aggregated 13F filings for Q4 2023.